Driving Innovation in Medical Motion Control

Key Takeaways

• Early engineer‑to‑engineer collaboration cuts redesign costs
• System‑level design reduces integration risk, speeds time‑to‑market
• Regal Rexnord unifies Portescap, Kollmorgen, Thomson for medical motion
• Miniature motors enable precise surgical tool articulation
• Global ISO‑certified production supports scalable device volumes

Summary

Motion control underpins modern medical devices such as surgical robots, imaging systems, and laboratory instruments, yet it remains a complex engineering hurdle. Dave Beckstoffer of Portescap highlights how early, collaborative partnerships with motion‑control specialists can streamline development and boost reliability. Regal Rexnord unites its brands—Portescap, Kollmorgen, and Thomson—into a unified portfolio that delivers system‑level, validated motion subsystems from prototype through production. This approach reduces integration risk, shortens time‑to‑market, and supports regulatory compliance for medtech OEMs.

Pulse Analysis

Motion control is the silent engine behind today’s most advanced medical equipment, from robotic surgeons to high‑throughput lab automation. The demand for sub‑millimeter precision, ultra‑quiet operation, and relentless reliability collides with stringent FDA and ISO regulations, making the design of actuators and drives a high‑risk endeavor. Traditional component‑by‑component sourcing often leads to integration bottlenecks, extended validation cycles, and costly redesigns. Consequently, device manufacturers are turning to specialist motion providers that can embed compliance and performance into the core architecture from day one.

Regal Rexnord answers that need with a systems‑led philosophy that treats motors, gearboxes, linear guides and control electronics as a single, validated subsystem. By leveraging the complementary strengths of Portescap’s miniature motors, Kollmorgen’s multi‑axis drives, and Thomson’s precision linear technologies, the company delivers ready‑to‑install motion packages tailored to surgical robots, imaging platforms and laboratory instruments. This integrated approach shortens prototype timelines, reduces mechanical tolerances, and ensures consistent performance throughout a device’s lifecycle, giving OEMs a clear path from concept to regulated production.

The cornerstone of this model is early, engineer‑to‑engineer collaboration. When motion experts join OEM teams at the ideation stage, they help define realistic performance targets, evaluate trade‑offs, and pre‑empt regulatory hurdles, thereby avoiding late‑stage redesigns that can derail launch schedules. Regal Rexnord’s global, ISO‑certified manufacturing network also guarantees that the same high‑quality motion solutions scale from low‑volume trials to mass production. For medtech firms, this partnership translates into faster innovation cycles, lower development risk, and ultimately, more reliable devices that improve patient outcomes.